Twomey Christopher J's Form 4 filing
Tandem Diabetes Care Inc (TNDM) · filed Jul 30, 2021
- Accession no.
- 0001438133-21-000110
- Filed
- Jul 30, 2021
- Trade date
- Jul 29, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $840.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Twomey Christopher JCIK 0001238935 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | Common Stock | SSaleDisposed | −5,000 | $105.00 | −$525,000 | 15,032 | Indirect | |
| Jul 29, 2021 | Common Stock | GGiftDisposed | −2,500 | $104.89F4 | −$262,225 | 12,532 | Indirect | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −3,000 | $105.00 | −$315,000 | 11,523 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.
Referenced by the price of 1 transaction in Table I.